Clinical research sites today grapple with the mounting complexity of trials. Rising administrative demands, intricate protocols, frequent staff turnover, and operational inefficiencies are pushing site teams to their limits, threatening to overwhelm even the most robust research programs.
We now stand at a pivotal moment where artificial intelligence (AI) offers a path to enhance operations, quality, and research capacity. Much like electronic data capture (EDC) systems revolutionized clinical trials two decades ago by replacing paper-based methods and becoming indispensable, AI is poised to become just as critical to trial execution. Integrating AI “teammates” into trial workflows may soon be essential for research sites to sustain their operations.
AI augmentation holds tremendous potential to streamline processes, ease site burdens, and elevate research quality. Drawing from our experiences at Georgia Retina—one of the largest retina practices in the Southeast—and through the broader evolution of technology in clinical trials, we are witnessing firsthand how AI is reshaping trials into more efficient, scalable, and patient-centric efforts.
Modern-day obstacles for clinical trial sites
Clinical research sites are the cornerstone of drug and device development, yet they continue to grapple with persistent, foundational challenges. These issues primarily fall into three critical areas: staff retention and training, administrative burdens, and financial management.
1. High staff turnover and demanding training needs
A leading challenge for research sites is frequent staff turnover and the extensive time required to train new employees. There is a chronic shortage of professionals who can seamlessly blend clinical expertise with research competencies. At Georgia Retina, we’ve experienced firsthand the difficulty of finding individuals who possess both ophthalmology knowledge and clinical trial experience. This field demands proficiency not just in clinical care, but also in research protocols, regulatory standards, and specialized testing procedures.
To bridge this gap, many sites hire technicians with clinical experience and then train them in research processes. However, this approach is not without obstacles. New staff must quickly grasp complex regulatory requirements, master rigorous data entry protocols, and understand the intricate nuances of clinical trial documentation—all while maintaining the exacting standards needed for ophthalmic studies, such as visual acuity testing and image capture. They must also develop strong communication skills to effectively engage with sponsors, CROs, and regulatory bodies. The steep learning curve means onboarding can take weeks or months, even as sponsors continue to expect flawless trial execution.
Here, AI can play a transformative role. Intelligent systems can ease training demands by offering structured learning paths and on-the-job, real-time guidance. They help standardize site operations across studies and support adherence to protocol-specific requirements. For technicians moving from clinical practice into research, AI tools can suggest terminology, navigate regulatory documentation, and provide critical contextual support.
The benefits extend well beyond initial training. AI continues to assist staff throughout their tenure by automatically checking data entries, flagging possible protocol deviations, and ensuring documentation consistency. This helps sustain quality and reduces the oversight burden on senior personnel.
2. Administrative burdens on site coordinators
Administrative tasks also divert site staff from patient-focused responsibilities. Coordinators often spend entire days managing regulatory paperwork, maintaining recruitment logs, communicating with sponsors, and performing data entry, leaving little time to engage with patients or focus on strategic study planning. Handling multiple studies—each with its unique systems and requirements—only compounds this workload, often leading to burnout and lower operational efficiency.
Communicating with sponsors, CROs, and regulatory authorities adds yet another layer of complexity. Coordinators must navigate these interactions while strictly adhering to protocol requirements, frequently resulting in redundant work and heightened stress.
Much of this administrative burden is inherently repetitive—such as compliance tracking, cross-checking study data, resolving queries, and managing financial processes. Without intervention, these tasks continue to erode the productivity of research teams.
3. Financial management inefficiencies
Financial oversight is perhaps one of the most overlooked challenges in clinical research. Many sites underbill for their services, not out of neglect, but due to the complex nature of trial budgets and invoicing. Each study comes with its own payment structure, making it difficult to accurately track and bill for all performed activities.
This complexity is compounded by how payments are issued: sites often receive lump-sum payments lacking detailed breakdowns, forcing staff to spend significant time reconciling payments against specific study activities. This financial opacity leads to underbilling and restricts the site’s ability to reinvest in growth or quality improvement initiatives.
